首页> 美国卫生研究院文献>other >Synergistic anti-inflammatory effects of Nobiletin and Sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells
【2h】

Synergistic anti-inflammatory effects of Nobiletin and Sulforaphane in lipopolysaccharide-stimulated RAW 264.7 cells

机译:脂多糖刺激的原料264.7细胞中Nobiletin和亚磺酸盐的协同抗炎作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inflammation plays important roles in initiation and progress of many diseases including cancers in multiple organ sites. Herein, we investigated the anti-inflammatory effects of two dietary compounds, nobiletin (NBN) and sulforaphane (SFN) in combination. Non-cytotoxic concentrations of NBN, SFN, and their combinations were studied in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. The results showed that combined NBN and SFN treatments produced much stronger inhibitory effects on the production of nitric oxide (NO) than NBN or SFN alone at higher concentrations. These enhanced inhibitory effects were synergistic based on the isobologram analysis. Western blot analysis showed that combined NBN and SFN treatments synergistically decreased iNOS and COX-2 protein expression levels and induced heme oxygenase-1 (HO-1) protein expression. Real-time PCR analysis indicated that low doses of NBN and SFN in combination significantly suppressed LPS-induced upregulation of IL-1 mRNA levels, and synergistically increased HO-1 mRNA levels. Overall our results demonstrated that NBN and SFN in combination produced synergistic effects in inhibiting LPS-induced inflammation in RAW 264.7 cells.
机译:炎症在许多疾病的开始和进展中起重要作用,包括多器官网站中的癌症。在此,我们研究了两种膳食化合物,Nobiletin(NBN)和亚磺甲烷(SFN)的抗炎作用。在脂多糖(LPS) - 刺激的原料264.7巨噬细胞中,研究了NBN,SFN的非细胞毒性浓度及其组合。结果表明,组合的NBN和SFN处理在较高浓度下单独生产高于NBN或SFN的一氧化氮(NO)产生更强烈的抑制作用。这些增强的抑制作用是基于异驱分析的协同作用。 Western印迹分析表明,NBN和SFN治疗组合协同降低的INOS和COX-2蛋白表达水平和诱导血红素氧酶-1(HO-1)蛋白表达。实时PCR分析表明,低剂量的NBN和SFN组合显着抑制了IL-1 mRNA水平的LPS诱导的UL-1 mRNA水平,以及协同增加的HO-1 mRNA水平。背景之利,我们的结果表明,NBN和SFN组合产生了抑制原始264.7细胞中的LPS诱导的炎症的协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号